News
VAXIMM completes enrollment of first oral cancer vaccine trial
www.openpr.com
[openPR (press release)] - Dr. Klaus Breiner, Executive Chairman of VAXIMM AG and Managing Partner at BB BIOTECH VENTURES commented: “Completing enrollment in record time is a great achievement. We are enthusiastic about the clinical potential of VXM01 for the treatment of
sortiert nach Relevanz / Datum